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warranted, particularly where utilization rates exceed
DVT incidence.
Table.
Procedure category
Primary
cases
(N)
Secondary VCF
utilization rate
(per 1000 cases)
DVT rate
(per 1000
cases)
Bariatric 69,814 2.49 1.58
Colon 108,898 0.38 7.77
Hepatobiliary 87,454 0.16 2.24
Peripheral vascular 22,445 0.62 7.31
Gastric (non-bariatric) 7,972 1.63 7.65
Amputation 6,312 1.58 8.40
Abdominal exploratory 7,811 1.28 13.95
Aortic 7,173 1.25 9.34
Hernia repair 51,520 0.16 1.98
Skin/soft tissue 3,463 2.30 4.90
Endocrine 2,019 3.47 2.97
Esophageal 13,143 0.46 5.25
Small bowel 14,454 0.42 12.94
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Objectives: The post thrombotic syndrome (PTS) is a
chronic condition that develops in 20% to 50% of patients
after deep venous thrombosis (DVT). It is characterized by
chronic pain, swelling and heaviness, and may result in
ulceration. Elastic compression stockings (ECS) worn daily
after DVT have been shown to reduce the incidence and
severity of PTS. The aim of our study was to investigate
practices and perceptions of physicians regarding adjunct
therapies to anticoagulation in patients diagnosed with
lover extremity DVT.
Methods: An online survey was conducted of Cana-
dian primary care staff physicians and residents (n685) to
investigate their attitudes towards prescription of ECS post
diagnosis of DVT.
Results: The results demonstrated that the majority of
staff physicians (58%) and residents (58%) were unsure
whether ECS were effective in preventing PTS and in
managing venous symptoms. This resulted in only 12% of
staff physicians and 26% of residents routinely prescribing
ECS for below-knee DVTs. Only 10% of staff physicians
and 12% of residents routinely prescribed ECS for above-
knee DVTs. More than 70% of respondents were unsure
about the optimal timing of initiation of ECS and duration
of therapy. A majority of staff and resident respondents
correctly predicted two out of the top three reasons for
patient non-compliance (soreness and the need for assis-
tance, but not cosmesis).
Conclusions: Daily use of graduated ECS after DVT
appears to reduce the risk of PTS. Our results demonstrate
that there is a lack of consensus among medics regarding
ECS use after DVT. There is a need for widespread educa-
tion regarding the latest evidence of the benefit of ECS
after DVT.
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Objectives: Current Chest guidelines counsel at least 3
months of anticoagulation (AC) to treat UEDVTs, yet are
not consistently followed among fragile patients. We
sought to correlate AC use with DVT characteristics and
patient outcomes.
Methods: Four hundred consecutive UEDVT patients
were identified between 2005 and 2009 from our Vascular
Lab Registry. Sonographic and patient characteristics, AC
treatment, PE incidence, mortality and hemorrhagic com-
plications were reviewed.
Results: Among the 400 patients, UEDVT was docu-
mented in the distal innominate (n91), internal jugular
(n 192), subclavian (n 211), axillary (n 146), and
brachial veins (n125). Most were symptomatic (n350,
88%), with sonographically acute appearance (n335,
84%). Many patients had documented malignancy
(n153, 38%), or associated central venous lines (n323,
81%), and most were treated with heparin and/or warfarin.
(n207, 52%). Thirteen patients (3%) suffered PE in asso-
ciation with their UEDVT diagnosis. There was no PE-
related mortality. Following discharge, 4 patients treated
with warfarin died from intracranial hemorrhage. Five ad-
ditional patients required hospital readmission for AC-
related intracranial, GI, and stomal hemorrhage.
Conclusions:AC ismost commonly used to treat more
extensive acute DVT components in younger patients with
better short-term survival. The incidence of PE does not
appear to be improved by AC treatment. Given the ob-
served morbidity and mortality associated with AC, and the
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